Related Experiment Video
Updated: Jul 7, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome
Vicente Barrios1,2, Álvaro Martín-Rivada1, Gabriel Á Martos-Moreno1,2,3
1Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Research Institute "La Princesa", Madrid 28009, Spain.
Insights
Children with Prader-Willi syndrome (PWS) show altered insulin-like growth factor (IGF) axis components. Increased pappalysin (PAPP-A) may enhance IGF-I bioavailability, impacting growth in PWS patients.
Area of Science:
- Endocrinology
- Pediatrics
- Genetics
Background:
- Prader-Willi syndrome (PWS) is linked to impaired growth hormone (GH) secretion and reduced insulin-like growth factor (IGF)-I levels.
- Pappalysins (PAPP-A, PAPP-A2) and stanniocalcins (STC-1, STC-2) modulate IGF binding protein (IGFBP) cleavage and IGF bioavailability, but their role in PWS is unclear.
Purpose of the Study:
- To determine serum levels of PAPP-As and STCs in relation to IGF axis components in prepubertal and pubertal PWS patients.
- To analyze the effects of GH treatment on these markers in children with PWS.
Main Methods:
- Studied 40 children and adolescents with PWS and 120 matched controls.
- Assessed serum levels of IGF-I, IGFBPs, PAPP-As, STCs, and acid-labile subunit.
- Evaluated the impact of 6-month GH treatment in 11 PWS children.
Main Results:
- PWS patients exhibited lower total IGF-I, IGFBP-3, and STC-1, but higher free IGF-I, IGFBP-5, and PAPP-A.
- Pubertal PWS patients showed decreased total IGF-I, IGFBP-3, and intact IGFBP-4, with increased total IGFBP-4 and STCs.
- GH treatment normalized total IGF-I, IGFBP-3, and IGFBP-4, without affecting PAPP-As or STCs.
Conclusions:
- Elevated PAPP-A in PWS may enhance IGF-I bioavailability through increased IGFBP proteolysis.
- Further research is needed to clarify the interplay between growth, GH resistance, and IGF axis dynamics in PWS.
- Findings suggest PAPP-A's potential role in the pathophysiology of growth disturbances in Prader-Willi syndrome.
Context:
Prader-Willi syndrome (PWS) is associated with impaired growth hormone (GH) secretion and decreased insulin-like growth factor (IGF)-I levels. Pappalysins (PAPP-A, PAPP-A2) and stanniocalcins (STC-1, STC-2) regulate IGF binding-protein (IGFBP) cleavage and IGF bioavailability, but their implication in PWS is unknown.
Objective:
We determined serum levels of PAPP-As and STCs in association with IGF axis components in prepubertal and pubertal patients with PWS, also analyzing the effect of GH treatment.
Methods:
Forty children and adolescents with PWS and 120 sex- and age-matched controls were included. The effect of GH was evaluated at 6 months of treatment in 11 children.
Results:
Children with PWS had lower levels of total IGF-I, total and intact IGFBP-3, acid-labile subunit, intact IGFBP-4, and STC-1, and they had higher concentrations of free IGF-I, IGFBP-5, and PAPP-A. Patients with PWS after pubertal onset had decreased total IGF-I, total and intact IGFBP-3, and intact IGFBP-4 levels, and had increased total IGFBP-4, and STCs concentrations. GH treatment increased total IGF-I, total and intact IGFBP-3, and intact IGFBP-4, with no changes in PAPP-As, STCs, and free IGF-I levels. Standardized height correlated directly with intact IGFBP-3 and inversely with PAPP-As and the free/total IGF-I ratio.
Conclusion:
The increase in PAPP-A could be involved in increased IGFBP proteolysis, promoting IGF-I bioavailability in children with PWS. Further studies are needed to establish the relationship between growth, GH resistance, and changes in the IGF axis during development and after GH treatment in these patients.
Related Concept Videos
Insulin Secretory Vesicles
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Cell Specific Gene Expression
TGF - β Signaling Pathway
Dipeptidyl Peptidase 4 Inhibitors
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

